These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 17803448)

  • 1. Recombinant expression of the beta-subunit of HLA-DR10 for the selection of novel lymphoma targeting molecules.
    Albrecht H; Cosman M; Ngu-Schwemlein M; Corzett M; Curran KW; Dolan C; Fang X; DeNardo SJ; DeNardo GL; Balhorn R
    Cancer Biother Radiopharm; 2007 Aug; 22(4):531-42. PubMed ID: 17803448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct antilymphoma activity of novel, first-generation "antibody mimics" that bind HLA-DR10-positive non-Hodgkin's lymphoma cells.
    West J; Perkins J; Hok S; Balhorn R; Lightstone FC; Cosman M; DeNardo SJ; DeNardo GL
    Cancer Biother Radiopharm; 2006 Dec; 21(6):645-54. PubMed ID: 17257080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of dimeric (bis) bidentate selective high affinity ligands as HLA-DR10 beta antibody mimics targeting non-Hodgkin's lymphoma.
    DeNardo GL; Hok S; Van Natarajan A; Cosman M; DeNardo SJ; Lightstone FC; Mirick GR; Yuan A; Perkins J; Sysko VV; Lehmann J; Balhorn RL
    Int J Oncol; 2007 Oct; 31(4):729-40. PubMed ID: 17786303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomolecular HLA-DR10 antibody mimics: A potent system for molecular targeted therapy and imaging.
    DeNardo GL; Natarajan A; Hok S; Mirick G; DeNardo SJ; Corzett M; Sysko V; Lehmann J; Beckett L; Balhorn R
    Cancer Biother Radiopharm; 2008 Dec; 23(6):783-96. PubMed ID: 20443696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic characterization in xenografted mice of a series of first-generation mimics for HLA-DR antibody, Lym-1, as carrier molecules to image and treat lymphoma.
    DeNardo GL; Natarajan A; Hok S; Perkins J; Cosman M; DeNardo SJ; Lightstone FC; Mirick GR; Miers LA; Balhorn RL
    J Nucl Med; 2007 Aug; 48(8):1338-47. PubMed ID: 17631545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and radiolabeling of selective high-affinity ligands designed to target non-Hodgkin's lymphoma and leukemia.
    Hok S; Natarajan A; Balhorn R; DeNardo SJ; DeNardo GL; Perkins J
    Bioconjug Chem; 2007; 18(3):912-21. PubMed ID: 17373772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoma-selective antibody Lym-1 recognizes a discontinuous epitope on the light chain of HLA-DR10.
    Rose LM; Gunasekera AH; DeNardo SJ; DeNardo GL; Meares CF
    Cancer Immunol Immunother; 1996 Sep; 43(1):26-30. PubMed ID: 8917632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A selective high affinity ligand (SHAL) designed to bind to an over-expressed human antigen on non-Hodgkin's lymphoma also binds to canine B-cell lymphomas.
    Balhorn RL; Skorupski KA; Hok S; Balhorn MC; Guerrero T; Rebhun RB
    Vet Immunol Immunopathol; 2010 Oct; 137(3-4):235-42. PubMed ID: 20576295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective high-affinity ligand antibody mimics for cancer diagnosis and therapy: initial application to lymphoma/leukemia.
    Balhorn R; Hok S; Burke PA; Lightstone FC; Cosman M; Zemla A; Mirick G; Perkins J; Natarajan A; Corzett M; DeNardo SJ; Albrecht H; Gregg JP; DeNardo GL
    Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5621s-5628s. PubMed ID: 17875798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lym-1-induced apoptosis of non-Hodgkin's lymphomas produces regression of transplanted tumors.
    Zhang N; Khawli LA; Hu P; Epstein AL
    Cancer Biother Radiopharm; 2007 Jun; 22(3):342-56. PubMed ID: 17651040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct antilymphoma effects on human lymphoma cells of monotherapy and combination therapy with CD20 and HLA-DR antibodies and 90Y-labeled HLA-DR antibodies.
    DeNardo GL; Tobin E; Chan K; Bradt BM; DeNardo SJ
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7075s-7079s. PubMed ID: 16203805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antilymphoma effects of anti-HLA-DR and CD20 monoclonal antibodies (Lym-1 and Rituximab) on human lymphoma cells.
    Liu C; DeNardo G; Tobin E; DeNardo S
    Cancer Biother Radiopharm; 2004 Oct; 19(5):545-61. PubMed ID: 15650447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular specific and cell selective cytotoxicity induced by a novel synthetic HLA-DR antibody mimic for lymphoma and leukemia.
    DeNardo GL; Mirick GR; Hok S; DeNardo SJ; Beckett LA; Adamson GN; Balhorn RL
    Int J Oncol; 2009 Feb; 34(2):511-6. PubMed ID: 19148487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hexa-arginine enhanced uptake and residualization of selective high affinity ligands by Raji lymphoma cells.
    Balhorn R; Hok S; DeNardo S; Natarajan A; Mirick G; Corzett M; Denardo G
    Mol Cancer; 2009 Apr; 8():25. PubMed ID: 19383174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The small molecule antibody mimic SH7139 targets a family of HLA-DRs expressed by B-cell lymphomas and other solid cancers.
    Balhorn R; Balhorn MC; Balakrishnan K; Rebhun RB
    J Drug Target; 2020 Dec; 28(10):1124-1136. PubMed ID: 32588667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody phage libraries for the next generation of tumor targeting radioimmunotherapeutics.
    DeNardo SJ; DeNardo GL; DeNardo DG; Xiong CY; Shi XB; Winthrop MD; Kroger LA; Carter P
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3213s-3218s. PubMed ID: 10541366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New polymorphic HLA-DR epitopes recognized by three monoclonal antibodies produced against DR103 transfected L cells.
    Cayrol C; Moro F; Sommer E; Tkaczuk J; Ohayon E; Cambon-Thomsen A
    Tissue Antigens; 1992 Oct; 40(4):197-203. PubMed ID: 1281933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterodimeric CD3epsilongamma extracellular domain fragments: production, purification and structural analysis.
    Kim KS; Sun ZY; Wagner G; Reinherz EL
    J Mol Biol; 2000 Sep; 302(4):899-916. PubMed ID: 10993731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between the amino-terminal domains of MHC class II molecules have a profound effect on serologic and T cell recognition: an analysis using recombinant HLA-DR/H-2E molecules.
    Barber LD; Lechler RI
    J Immunol; 1991 Oct; 147(7):2346-53. PubMed ID: 1717556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a novel monoclonal antibody with restricted specificity to the free beta 2 integrin alpha M CD11b subunit.
    Tanfous NG; Essafi M; Larguech B; Barbouche R; Fathallah DM
    Hybridoma (Larchmt); 2007 Dec; 26(6):373-9. PubMed ID: 18158781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.